A detailed history of Robeco Institutional Asset Management B.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 3,565,758 shares of ABBV stock, worth $642 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
3,565,758
Previous 3,303,442 7.94%
Holding current value
$642 Million
Previous $567 Million 24.28%
% of portfolio
1.42%
Previous 1.23%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $43 Million - $52.3 Million
262,316 Added 7.94%
3,565,758 $704 Million
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $4.54 Million - $5.3 Million
29,346 Added 0.9%
3,303,442 $567 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $176 Million - $201 Million
1,101,089 Added 50.67%
3,274,096 $596 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $113 Million - $127 Million
821,803 Added 60.82%
2,173,007 $337 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $24.9 Million - $28.1 Million
-181,086 Reduced 11.82%
1,351,204 $2.17 Billion
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $2.72 Million - $3.14 Million
20,333 Added 1.34%
1,532,290 $228 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $1.7 Million - $2.12 Million
12,832 Added 0.86%
1,511,957 $204 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $31.6 Million - $36.4 Million
-218,642 Reduced 12.73%
1,499,125 $239 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $46.5 Million - $55.8 Million
-336,458 Reduced 16.38%
1,717,767 $278 Million
Q3 2022

Dec 01, 2022

SELL
$134.21 - $153.93 $23 Million - $26.4 Million
-171,708 Reduced 7.71%
2,054,225 $276 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $23 Million - $26.4 Million
-171,708 Reduced 7.71%
2,054,225 $276 Million
Q2 2022

Dec 01, 2022

BUY
$137.62 - $174.96 $39.8 Million - $50.6 Million
289,108 Added 14.93%
2,225,933 $341 Million
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $39.8 Million - $50.6 Million
289,108 Added 14.93%
2,225,933 $341 Million
Q1 2022

Dec 01, 2022

BUY
$131.98 - $163.75 $117 Million - $145 Million
887,064 Added 84.5%
1,936,825 $314 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $117 Million - $145 Million
887,064 Added 84.5%
1,936,825 $314 Million
Q4 2021

Dec 01, 2022

BUY
$107.43 - $135.93 $33 Million - $41.8 Million
307,472 Added 41.42%
1,049,761 $142 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $33 Million - $41.8 Million
307,472 Added 41.42%
1,049,761 $142 Million
Q3 2021

Dec 01, 2022

BUY
$106.4 - $120.78 $70,756 - $80,318
665 Added 0.09%
742,289 $80.1 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $70,756 - $80,318
665 Added 0.09%
742,289 $80.1 Million
Q2 2021

Dec 01, 2022

SELL
$105.21 - $117.21 $83.8 Million - $93.3 Million
-796,348 Reduced 51.78%
741,624 $83.5 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $83.8 Million - $93.3 Million
-796,348 Reduced 51.78%
741,624 $83.5 Million
Q1 2021

Dec 01, 2022

SELL
$102.3 - $112.62 $52.8 Million - $58.1 Million
-516,253 Reduced 25.13%
1,537,972 $166 Million
Q1 2021

Apr 23, 2021

SELL
$102.3 - $112.62 $38.6 Million - $42.5 Million
-377,401 Reduced 19.7%
1,537,972 $166 Million
Q4 2020

Dec 01, 2022

SELL
$80.49 - $108.67 $11.2 Million - $15.1 Million
-138,852 Reduced 6.76%
1,915,373 $205 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $71 Million - $95.8 Million
-881,488 Reduced 31.52%
1,915,373 $205 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $2.02 Million - $2.38 Million
-23,568 Reduced 0.84%
2,796,861 $245 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $4.64 Million - $6.21 Million
63,217 Added 2.29%
2,820,429 $277 Million
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $3.9 Million - $5.92 Million
-60,495 Reduced 2.15%
2,757,212 $210 Million
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $7.08 Million - $8.86 Million
-98,168 Reduced 3.37%
2,817,707 $249 Million
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $22.1 Million - $26.6 Million
350,870 Added 13.68%
2,915,875 $221 Million
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $64.4 Million - $82.3 Million
979,638 Added 61.79%
2,565,005 $187 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $21.5 Million - $25.3 Million
278,226 Added 21.29%
1,585,367 $128 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $8.24 Million - $10.2 Million
-105,891 Reduced 7.49%
1,307,141 $120 Million
Q3 2018

Oct 31, 2018

BUY
$88.91 - $98.84 $126 Million - $140 Million
1,413,032 New
1,413,032 $134 Million
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $102 Million - $113 Million
-1,143,797 Closed
0 $0
Q2 2018

Jan 19, 2021

BUY
$89.78 - $106.23 $103 Million - $122 Million
1,143,797 New
1,143,797 $106 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $100 Million - $119 Million
-1,115,661 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $5.38 Million - $7.2 Million
-58,444 Reduced 4.98%
1,115,661 $106 Million
Q4 2017

Jan 25, 2018

BUY
$89.56 - $98.21 $22.8 Million - $25 Million
254,587 Added 27.69%
1,174,105 $114 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $1.56 Million - $1.99 Million
22,264 Added 2.48%
919,518 $81.7 Million
Q2 2017

Aug 08, 2017

SELL
N/A
-66,552 Reduced 6.91%
897,254 $65.1 Million
Q1 2017

Jan 19, 2021

BUY
N/A
963,806
963,806 $62.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.